Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol valerate/dienogest versus Microgynon for reduced libido associated with oral contraceptive use
2008-002263-13Phase 3Completed
- Sponsor
- Bayer
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in female sexual dysfunction (FSD) comparing SH T00658ID with Microgynon (2 arms). Primary endpoint: Change in FSFI desire and arousal score from baseline to cycle 6. Started Oct 2008; status: completed.
02
Drugs
estradiol valerate + dienogestethinylestradiol + levonorgestrel
03
Conditions
female sexual dysfunction (FSD)
Beyond the preview
Go deeper on 2008-002263-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002263-13.